© 1998 by European Society of Cardiology
Copyright © 1998, European Society of Cardiology
Lessons from rat models of hypertension
from Goldblatt to genetic engineering
aDepartment of Clinical Pharmacology and Toxicology, Benjamin Franklin Medical Center, Free University Berlin, Berlin, Germany
bMax Delbrück Center for Molecular Medicine, Berlin-Buch, Berlin, Germany
* Corresponding author. Tel.: +49 (30) 8445 2279; Fax: +49 (30) 8445 4482; E-mail: pinto@ukbf.fu-berlin.de
Over the past 50 years various animal models of hypertension have been developed, predominantly in the rat. In this review we discuss the use of the rat as a model of hypertension, and evaluate what these models have taught us. Interestingly, the spontaneously hypertensive rat (SHR) is by far the most widely used rat model, although it reflects only a rare subtype of human hypertension, i.e. primary hypertension that is inherited in a Mendelian fashion. Many other aspects of the etiology of hypertension are found in other rat models, but these models are less frequently employed. The widespread use of the SHR suggests that this rat model is often chosen without considering alternative (and possibly better suited) models. To illustrate the importance of the choice for a particular model, we compared the natural history and response to antihypertensive drugs in different rat models of hypertension (SHR, Dahl, deoxycorticosterone acetate (DOCA)–salt, two-kidney one-clip, transgenic TGR(mRen2)27. This revealed that the outcome of hypertension can be similar in some respects, as all models exhibit cardiac hypertrophy, and all demonstrate impaired endothelium-dependent relaxations. However, the more severe forms of end-organ damage such as heart failure, stroke and kidney failure, occur only in some models and then only in a subset of the hypertensive rats. The effects of antihypertensives varies even more in the different models: antihypertensive treatment only attenuates end-organ damage if it decreases blood pressure. Moreover, if a given antihypertensive is effective, it sometimes even attenuates end-organ damage in nonhypotensive doses. On the other hand, some agents do decrease blood pressure but do not prevent end-organ damage (e.g. hydralazine in SHR). Furthermore, not all classes of antihypertensives are equally effective in all rat models of hypertension: endothelin-receptor antagonists are not effective in SHR, but have beneficial effects in the DOCA–salt model. The comparison of models, and the comparison of treatment effects suggests that end-organ damage critically depends upon not only on the stress imposed by high blood pressure and its underlying biochemical disturbance, but also upon the ability of the organism to recruit adequate ‘coping’ mechanisms. These coping mechanisms deserve greater attention, as failure to recruit such mechanisms may indicate an increased risk. The current development of transgenic techniques will provide new opportunities, to develop specific models to address this balance between stress and coping.
KEYWORDS Hypertension; Animal models; End-organ damage; Genetic
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C.-J. Lee, R.-P. Lee, Y.-M. Subeq, C.-C. Lee, T.-C. Peng, and B.-G. Hsu Propofol Protects Against Hemorrhagic Shock-Induced Organ Damage in Conscious Spontaneously Hypertensive Rats Biol Res Nurs, October 1, 2009; 11(2): 152 - 162. [Abstract] [PDF]
|
|
|
|
 |
|
 A. A. Tobin, B. K. Joseph, H. N. Al-Kindi, S. Albarwani, J. A. Madden, L. T. Nemetz, N. J. Rusch, and S. W. Rhee Loss of cerebrovascular Shaker-type K+ channels: a shared vasodilator defect of genetic and renal hypertensive rats Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H293 - H303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Abramowitz and L. Birnbaumer Physiology and pathophysiology of canonical transient receptor potential channels FASEB J, February 1, 2009; 23(2): 297 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Kolwicz, H. Kubo, S. M. MacDonnell, S. R. Houser, and J. R. Libonati Effects of forskolin on inotropic performance and phospholamban phosphorylation in exercise-trained hypertensive myocardium J Appl Physiol, February 1, 2007; 102(2): 628 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Diez-Freire, J. Vazquez, M. F. Correa de Adjounian, M. F. R. Ferrari, L. Yuan, X. Silver, R. Torres, and M. K. Raizada ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR Physiol Genomics, January 12, 2007; 27(1): 12 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Doe, R. Bentley, D. J. Behm, R. Lafferty, R. Stavenger, D. Jung, M. Bamford, T. Panchal, E. Grygielko, L. L. Wright, et al. Novel Rho Kinase Inhibitors with Anti-inflammatory and Vasodilatory Activities J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 89 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Iwamoto Vascular Na+/Ca2+ exchanger: implications for the pathogenesis and therapy of salt-dependent hypertension Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R536 - R545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, N. E. Kaminski, and D. H. Wang VR1-Mediated Depressor Effects During High-Salt Intake: Role of Anandamide Hypertension, October 1, 2005; 46(4): 986 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N Kharin, V. V Krandycheva, and D. N Shmakov Depolarization pattern of ventricular epicardium in two-kidney one-clip hypertensive rats Exp Physiol, July 1, 2005; 90(4): 621 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Forster, S. Kietz, K. Hultenby, M. Warner, and J.-A. Gustafsson Characterization of the ER{beta}-/-mouse heart PNAS, September 28, 2004; 101(39): 14234 - 14239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Pesic, J. A. Madden, M. Pesic, and N. J. Rusch High Blood Pressure Upregulates Arterial L-Type Ca2+ Channels: Is Membrane Depolarization the Signal? Circ. Res., May 28, 2004; 94(10): e97 - e104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yang, P. Y. Reaves, M. J. Katovich, and M. K. Raizada Decrease in Hypothalamic Gamma Adducin in Rat Models of Hypertension Hypertension, February 1, 2004; 43(2): 324 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Fine, P. Ariza-Nieto, and J. W. Osborn Does whole body autoregulation mediate the hemodynamic responses to increased dietary salt in rats with clamped ANG II? Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2670 - H2678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ulker, D. McMaster, P. P. McKeown, and U. Bayraktutan Impaired activities of antioxidant enzymes elicit endothelial dysfunction in spontaneous hypertensive rats despite enhanced vascular nitric oxide generation Cardiovasc Res, August 1, 2003; 59(2): 488 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Boknik, I. Heinroth-Hoffmann, U. Kirchhefer, J. Knapp, B. Linck, H. Luss, T. Muller, W. Schmitz, O.-E. Brodde, and J. Neumann Enhanced protein phosphorylation in hypertensive hypertrophy Cardiovasc Res, September 1, 2001; 51(4): 717 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. M. Pinto, S.-J. Pinto-Sietsma, T. Philipp, S. Engler, P. Ko{beta}mehl, B. Hocher, H. Marquardt, S. Sethmann, R. Lauster, H.-J. Merker, et al. Reduction in Left Ventricular Messenger RNA for Transforming Growth Factor {beta}1 Attenuates Left Ventricular Fibrosis and Improves Survival Without Lowering Blood Pressure in the Hypertensive TGR(mRen2)27 Rat Hypertension, November 1, 2000; 36(5): 747 - 754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. H. Wang, X.-J. Du, D. J. Autelitano, C. A. Milano, and E. A. Woodcock Adverse effects of constitutively active alpha 1B-adrenergic receptors after pressure overload in mouse hearts Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1079 - H1086. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Hocher and M. Paul Transgenic animal models for the analysis of the renal endothelin system Nephrol. Dial. Transplant., July 1, 2000; 15(7): 935 - 937. [Full Text] [PDF]
|
|
|
|
|
|
Z. Fang, S. H. Carlson, N. Peng, and J. M. Wyss Circadian rhythm of plasma sodium is disrupted in spontaneously hypertensive rats fed a high-NaCl diet Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2000; 278(6): R1490 - R1495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Garcia-Villalon, L. Monge, N. Fernandez, M. A. Sanchez, M. A. Martinez, B. Gomez, and G. Dieguez Impaired potentiation by endothelin-1 and vasopressin of sympathetic contraction in tail artery from hypertensive rats Cardiovasc Res, January 14, 2000; 45(2): 463 - 469. [Abstract] [Full Text] [PDF]
|
|